BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Lu Z, Zhao X. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol. 2019;12:133. [PMID: 31815633 DOI: 10.1186/s13045-019-0806-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao S, Long F, Jiang Z, Shi J, Ma D, Yang Y, Bai J, Han T. The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle age. Front Physiol 2022;13:990987. [DOI: 10.3389/fphys.2022.990987] [Reference Citation Analysis]
2 Jia M, Jia J, Xu J, Xue H. . CMAR 2022;Volume 14:2625-38. [DOI: 10.2147/cmar.s372125] [Reference Citation Analysis]
3 Xu L, Wu H, Pan J, Chen Z, Du L, Li T. Significance of lncRNA CDKN2B-AS1 in Interventional Therapy of Liver Cancer and the Mechanism under Its Participation in Tumour Cell Growth via miR-199a-5p. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/2313416] [Reference Citation Analysis]
4 Wang WT, Jin WL, Li X. Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma. Biochim Biophys Acta Mol Basis Dis 2022;1868:166528. [PMID: 36007784 DOI: 10.1016/j.bbadis.2022.166528] [Reference Citation Analysis]
5 Laface C, Fedele P, Maselli FM, Ambrogio F, Foti C, Molinari P, Ammendola M, Lioce M, Ranieri G. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers (Basel) 2022;14:4028. [PMID: 36011021 DOI: 10.3390/cancers14164028] [Reference Citation Analysis]
6 Liu J, Xiao P, Jiang W, Wang Y, Huang Y. Diagnostic value of exosomes in patients with liver cancer: a systematic review. Clin Transl Oncol 2022. [PMID: 35947296 DOI: 10.1007/s12094-022-02906-8] [Reference Citation Analysis]
7 Jin C, Zhao JS, Huang XQ, Yang XZ, Niu FY, Lin JR, Ma L, Shi YX, Li XS, Jiang P, Gao S, Li F, Song Y. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35947245 DOI: 10.1007/s12072-022-10375-y] [Reference Citation Analysis]
8 Li S, Zhu Y, Haghniaz R, Kawakita S, Guan S, Chen J, Li Z, Mandal K, Bahari J, Shah S, Guo J, Kang H, Sun W, Kim H, Jucaud V, Dokmeci MR, Kollbaum P, Lee CH, Khademhosseini A. A Microchambers Containing Contact Lens for the Noninvasive Detection of Tear Exosomes. Adv Funct Materials. [DOI: 10.1002/adfm.202206620] [Reference Citation Analysis]
9 Xu W, Yu M, Wu Y, Jie Y, Li X, Zeng X, Yang F, Chong Y. Plasma-Derived Exosomal SncRNA as a Promising Diagnostic Biomarker for Early Detection of HBV-Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2022;12:923300. [DOI: 10.3389/fcimb.2022.923300] [Reference Citation Analysis]
10 Wu X, Wei Z, Feng H, Chen H, Xie J, Huang Y, Wang M, Yao C, Huang J. Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro. J Pharm Sci 2022:S0022-3549(22)00258-1. [PMID: 35779664 DOI: 10.1016/j.xphs.2022.06.015] [Reference Citation Analysis]
11 Hu C, Jiang W, Lv M, Fan S, Lu Y, Wu Q, Pi J. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy. Front Immunol 2022;13:792046. [PMID: 35757760 DOI: 10.3389/fimmu.2022.792046] [Reference Citation Analysis]
12 Liang X, Song F, Fang W, Zhang Y, Feng Z, Chen Z, Han L, Chen Z. CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma. Int J Gen Med 2022;15:5661-72. [PMID: 35734199 DOI: 10.2147/IJGM.S363050] [Reference Citation Analysis]
13 Gulati R, Nandi D, Sarkar K, Venkataraman P, Ramkumar KM, Ranjan P, Janardhanan R. Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers. Front Mol Biosci 2022;9:890768. [DOI: 10.3389/fmolb.2022.890768] [Reference Citation Analysis]
14 Liu Y, Zhang Y, Du D, Gu X, Zhou S. PCDH17 is regulated by methylation of DNMT3B and affects the malignant biological behavior of HCC through EMT. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113245] [Reference Citation Analysis]
15 Batool S, Javed MR, Aslam S, Noor F, Javed HMF, Seemab R, Rehman A, Aslam MF, Paray BA, Gulnaz A. Network Pharmacology and Bioinformatics Approach Reveals the Multi-Target Pharmacological Mechanism of Fumaria indica in the Treatment of Liver Cancer. Pharmaceuticals 2022;15:654. [DOI: 10.3390/ph15060654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhao H, Liu H, Yang Y, Wang H. The Protective Role of 4-Acetylarylquinolinol B in Different Pathological Processes. CIMB 2022;44:2362-73. [DOI: 10.3390/cimb44050161] [Reference Citation Analysis]
17 Wu Y, Xu X, Liu M, Qin X, Wu Q, Ding H, Zhao Q. DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochem Pharmacol 2022;:115093. [PMID: 35580648 DOI: 10.1016/j.bcp.2022.115093] [Reference Citation Analysis]
18 Wang Z, Zhong Y, Zhang Z, Zhou K, Huang Z, Yu H, Liu L, Liu S, Yang H, Zhou J, Fan J, Wu L, Sun Y. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma. Front Immunol 2022;13:847263. [PMID: 35371059 DOI: 10.3389/fimmu.2022.847263] [Reference Citation Analysis]
19 Wang L, Guo Y, Zhang H, Li H, Wang F, Zhang J, Li X, M.a B. Risk Factors for Brain Metastasis of Hepatocellular Carcinoma. Journal of Healthcare Engineering 2022;2022:1-5. [DOI: 10.1155/2022/7848143] [Reference Citation Analysis]
20 Yang JC, Hu JJ, Li YX, Luo W, Liu JZ, Ye DW. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma. Front Oncol 2022;12:781820. [PMID: 35211399 DOI: 10.3389/fonc.2022.781820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chen H, Tang C, Tan C, Wu F, Li Z, Ji W, Lu L, Xu C, Shen Z, Huang Y, Ding X. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3445350] [Reference Citation Analysis]
22 Dao TNT, Kim MG, Koo B, Liu H, Jang YO, Lee HJ, Kim Y, Park Y, Kim HS, Kim C, Shin Y. Chimeric nanocomposites for the rapid and simple isolation of urinary extracellular vesicles. J of Extracellular Vesicle 2022;11. [DOI: 10.1002/jev2.12195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Hsu MT, Wang YK, Tseng YJ. Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment. Cancers (Basel) 2022;14:732. [PMID: 35158999 DOI: 10.3390/cancers14030732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Chen Y, Shang H, Wang C, Zeng J, Zhang S, Wu B, Cheng W. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC. Int J Nanomedicine 2022;17:105-23. [PMID: 35027829 DOI: 10.2147/IJN.S343361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
26 Li L, Niu L, Guo N, Cheng L, Hao T, Xu Y, Li X, Xu Q, Liu L, Yang S. Identification of Driver Genes in Primary Liver Cancer by Integrating NGS and TCGA Mutation Data. OJGas 2022;12:1-18. [DOI: 10.4236/ojgas.2022.121001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Elghoroury EA, Abdelghaffar EE, Awadallah E, Kamel SA, Kandil D, Hassan EM, Hassan M, Kamel MM, Gomaa MM, Fathalla LA. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221097832. [PMID: 35467432 DOI: 10.1177/03946320221097832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chang Q, Wu J, An Y, Liu H, Sun Y. Propofol suppresses proliferation, migration, invasion, and tumor growth of liver cancer cells via suppressing cancer susceptibility candidate 9/phosphatase and tensin homolog/AKT serine/threonine kinase/mechanistic target of rapamycin kinase axis. Hum Exp Toxicol 2022;41:9603271211065972. [PMID: 35238236 DOI: 10.1177/09603271211065972] [Reference Citation Analysis]
29 Mao X, Mei R, Yu S, Shou L, Zhang W, Li K, Qiu Z, Xie T, Sui X. Emerging Technologies for the Detection of Cancer Micrometastasis. Technol Cancer Res Treat 2022;21:15330338221100355. [PMID: 35903930 DOI: 10.1177/15330338221100355] [Reference Citation Analysis]
30 He GH, Ma YX, Dong M, Chen S, Wang YC, Gao X, Wu B, Wang J, Wang JH. Mesenchymal stem cell-derived exosomes inhibit the VEGF-A expression in human retinal vascular endothelial cells induced by high glucose. Int J Ophthalmol 2021;14:1820-7. [PMID: 34926194 DOI: 10.18240/ijo.2021.12.03] [Reference Citation Analysis]
31 You X, Sun W, Wang Y, Liu X, Wang A, Liu L, Han S, Sun Y, Zhang J, Guo L, Zhang Y. Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells. Cancer Cell Int 2021;21:684. [PMID: 34923985 DOI: 10.1186/s12935-021-02379-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Gong Y, Li K, Qin Y, Zeng K, Liu J, Huang S, Chen Y, Yu H, Liu W, Ye L, Yang Y. Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma. Front Oncol 2021;11:711448. [PMID: 34888230 DOI: 10.3389/fonc.2021.711448] [Reference Citation Analysis]
33 Xue Y, Feng X, Fan X, Zhu G, Mclaughlan J, Zhang W, Chen X. Extracellular Vesicles for the Diagnosis of Cancers. Small Structures 2022;3:2100096. [DOI: 10.1002/sstr.202100096] [Reference Citation Analysis]
34 Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
35 Zhu S, Li S, Yi M, Li N, Wu K. Roles of Microvesicles in Tumor Progression and Clinical Applications. Int J Nanomedicine 2021;16:7071-90. [PMID: 34703228 DOI: 10.2147/IJN.S325448] [Reference Citation Analysis]
36 Li L, Zhao J, Zhang Q, Tao Y, Shen C, Li R, Ma Z, Li J, Wang Z. Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway. Front Oncol 2021;11:756205. [PMID: 34692546 DOI: 10.3389/fonc.2021.756205] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Shen B, Sun K. Exosomal circular RNAs: A new frontier in the metastasis of digestive system tumors. Oncol Lett 2021;22:826. [PMID: 34691253 DOI: 10.3892/ol.2021.13087] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Yin S, Yang S, Luo Y, Lu J, Hu G, Wang K, Shao Y, Zhou S, Koo S, Qiu Y, Wang T, Yu H. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma. Biochem Pharmacol 2021;193:114806. [PMID: 34673013 DOI: 10.1016/j.bcp.2021.114806] [Reference Citation Analysis]
39 Hayashi S, Nagaoka K, Tanaka Y. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins. Int J Mol Sci 2021;22:11051. [PMID: 34681709 DOI: 10.3390/ijms222011051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang Y, Zuo Z, Liu B, Yang P, Wu J, Han L, Han T, Chen T. FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC. J Gastrointest Oncol 2021;12:1823-37. [PMID: 34532131 DOI: 10.21037/jgo-21-374] [Reference Citation Analysis]
41 Zhao Z, Yang S, Zhou A, Li X, Fang R, Zhang S, Zhao G, Li P. Small Extracellular Vesicles in the Development, Diagnosis, and Possible Therapeutic Application of Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:732702. [PMID: 34527593 DOI: 10.3389/fonc.2021.732702] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
42 Huang Z, Su G, Bi X, Zhang L, Xu Z, Wang G. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway. Bioengineered 2021;12:6952-66. [PMID: 34516353 DOI: 10.1080/21655979.2021.1975016] [Reference Citation Analysis]
43 Zhu J, Tang B, Gao Y, Xu S, Tu J, Wang Y, Yang W, Fang S, Weng Q, Zhao Z, Xu M, Yang Y, Chen M, Lu C, Ji J. Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2. J Inflamm Res 2021;14:4089-109. [PMID: 34466015 DOI: 10.2147/JIR.S315957] [Reference Citation Analysis]
44 Fu X, Tang Y, Wu W, Ouyang Y, Tan D, Huang Y. Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis. Dig Liver Dis 2021:S1590-8658(21)00385-6. [PMID: 34384713 DOI: 10.1016/j.dld.2021.07.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Liu P, Xia P, Fu Q, Liu C, Luo Q, Cheng L, Yu P, Qin T, Zhang H. miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest. Biochem Biophys Res Commun 2021;571:96-103. [PMID: 34314996 DOI: 10.1016/j.bbrc.2021.07.035] [Reference Citation Analysis]
46 Hao L, Li S, Peng Q, Guo Y, Ji J, Zhang Z, Xue Y, Liu Y, Shi X. Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer. Oncol Lett 2021;22:653. [PMID: 34386075 DOI: 10.3892/ol.2021.12914] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
47 Zhao Z, Zhao G, Yang S, Zhu S, Zhang S, Li P. The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer. Cancer Cell Int 2021;21:364. [PMID: 34243775 DOI: 10.1186/s12935-021-02059-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Lee YT, Tran BV, Wang JJ, Liang IY, You S, Zhu Y, Agopian VG, Tseng HR, Yang JD. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3076. [PMID: 34203086 DOI: 10.3390/cancers13123076] [Reference Citation Analysis]
49 Xiang D, Li Y, Cao Y, Huang Y, Zhou L, Lin X, Qiao Y, Li X, Liao D. Different Effects of Endothelial Extracellular Vesicles and LPS-Induced Endothelial Extracellular Vesicles on Vascular Smooth Muscle Cells: Role of Curcumin and Its Derivatives. Front Cardiovasc Med 2021;8:649352. [PMID: 34150863 DOI: 10.3389/fcvm.2021.649352] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
50 Tan Y, Luo X, Lv W, Hu W, Zhao C, Xiong M, Yi Y, Wang D, Wang Y, Wang H, Wu Y, Zhang Q. Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis. Cell Death Dis 2021;12:547. [PMID: 34039961 DOI: 10.1038/s41419-021-03825-2] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
51 Zhang L, Lu Z, Zhao X. Targeting Bcl-2 for cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1876:188569. [PMID: 34015412 DOI: 10.1016/j.bbcan.2021.188569] [Reference Citation Analysis]
52 Guan MC, Ouyang W, Wang MD, Liang L, Li N, Fu TT, Shen F, Lau WY, Xu QR, Huang DS, Zhu H, Yang T. Biomarkers for hepatocellular carcinoma based on body fluids and feces. World J Gastrointest Oncol 2021; 13(5): 351-365 [PMID: 34040698 DOI: 10.4251/wjgo.v13.i5.351] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Sorop A, Constantinescu D, Cojocaru F, Dinischiotu A, Cucu D, Dima SO. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4997. [PMID: 34066780 DOI: 10.3390/ijms22094997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Liu C, Wu H, Mao Y, Chen W, Chen S. Exosomal microRNAs in hepatocellular carcinoma. Cancer Cell Int 2021;21:254. [PMID: 33964930 DOI: 10.1186/s12935-021-01941-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 He C, Jaffar Ali D, Aseervatham G SB, Sun B, Xiao Z. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacol Res 2021;169:105609. [PMID: 33852962 DOI: 10.1016/j.phrs.2021.105609] [Reference Citation Analysis]
56 Qin L, Zhan Z, Wei C, Li X, Zhang T, Li J. Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer. Mol Med Rep 2021;23:421. [PMID: 33864660 DOI: 10.3892/mmr.2021.12060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wang Y, Gao R, Li J, Tang S, Li S, Tong Q, Li S. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization. Int J Nanomedicine 2021;16:2803-18. [PMID: 33880025 DOI: 10.2147/IJN.S284560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Zhao WT, Han LX, Liu L, Zeng BZ, Zhang Y, Zhao LF, Hu HY, Xia JW, Li YZ, Xiang XD, Lin XL, Lu D, Li GF. The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway. J Cancer 2021;12:3325-34. [PMID: 33976742 DOI: 10.7150/jca.56426] [Reference Citation Analysis]
59 Gu X, Zhang J, Ran Y, Pan H, Jia J, Zhao Y, Zhao X, Li W, Song S, Yu X. Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression. Cell Death Dis 2021;12:356. [PMID: 33824281 DOI: 10.1038/s41419-021-03626-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
60 He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomed Pharmacother 2021;138:111529. [PMID: 34311529 DOI: 10.1016/j.biopha.2021.111529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li H, Huang H, Li S, Mei H, Cao T, Lu Q. Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion. Exp Ther Med 2021;21:559. [PMID: 33850531 DOI: 10.3892/etm.2021.9991] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
62 Liu Y, Shi K, Chen Y, Wu X, Chen Z, Cao K, Tao Y, Chen X, Liao J, Zhou J. Exosomes and Their Role in Cancer Progression. Front Oncol 2021;11:639159. [PMID: 33828985 DOI: 10.3389/fonc.2021.639159] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
63 Yao B, Li Y, Chen T, Niu Y, Wang Y, Yang Y, Wei X, Liu Q, Tu K. Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway. Clin Transl Med 2021;11:e366. [PMID: 33784016 DOI: 10.1002/ctm2.366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Liu J, Liu Z, Li W, Zhang S. SOCS2 is a potential prognostic marker that suppresses the viability of hepatocellular carcinoma cells. Oncol Lett 2021;21:399. [PMID: 33777222 DOI: 10.3892/ol.2021.12660] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
65 Gu Y, Wang C, Chen S, Tang J, Guo X, Hu W, Cui A, Zhang D, Yu K, Chen M. A Critical Role of Peptidylprolyl Isomerase A Pseudogene 22/microRNA-197-3p/Peptidylprolyl Isomerase A Axis in Hepatocellular Carcinoma. Front Genet 2021;12:604461. [PMID: 33790943 DOI: 10.3389/fgene.2021.604461] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Song T, Li L, Wu S, Liu Y, Guo C, Wang W, Dai L, Zhang T, Wu H, Su B. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Front Oncol 2021;11:583714. [PMID: 33777736 DOI: 10.3389/fonc.2021.583714] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Su C, Zhang J, Yarden Y, Fu L. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther 2021;6:109. [PMID: 33678805 DOI: 10.1038/s41392-021-00499-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
68 Chen X, Yan N. Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways. Anticancer Drugs 2021;32:786-92. [PMID: 33675608 DOI: 10.1097/CAD.0000000000001066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Li X, Dong G, Xiong H, Diao H. A narrative review of the role of necroptosis in liver disease: a double-edged sword. Ann Transl Med 2021;9:422. [PMID: 33842643 DOI: 10.21037/atm-20-5162] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
70 Zhao G, Zhou A, Li X, Zhu S, Wang Y, Zhang S, Li P. The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer. Genes (Basel) 2021;12:73. [PMID: 33430032 DOI: 10.3390/genes12010073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
71 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
72 Słomka A, Mocan T, Wang B, Nenu I, Urban SK, Gonzales-Carmona M, Schmidt-Wolf IGH, Lukacs-Kornek V, Strassburg CP, Spârchez Z, Kornek M. EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC. Cancers (Basel) 2020;12:E3019. [PMID: 33080904 DOI: 10.3390/cancers12103019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
73 Li S, Wang X. The potential roles of exosomal noncoding RNAs in osteosarcoma. J Cell Physiol 2021;236:3354-65. [PMID: 33044018 DOI: 10.1002/jcp.30101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wang J, Miao Y, Ran J, Yang Y, Guan Q, Mi D. Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma. Biomark Med 2020;14:1229-42. [PMID: 33021390 DOI: 10.2217/bmm-2020-0170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Yu W, Zeng H, Chen J, Fu S, Huang Q, Xu Y, Xu A, Lan H, Tang Y. miR-20a-5p is enriched in hypoxia-derived tubular exosomes and protects against acute tubular injury. Clinical Science 2020;134:2223-34. [DOI: 10.1042/cs20200288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
76 Wu A, Li Y, Kong M, Zhu B, Liu R, Bao F, Ju S, Chen L, Wang F. Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis. Front Oncol 2020;10:1388. [PMID: 32974140 DOI: 10.3389/fonc.2020.01388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
77 Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, Tao Y, He Z, Chen C, Jiang Y. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5:145. [PMID: 32759948 DOI: 10.1038/s41392-020-00261-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 222] [Article Influence: 38.5] [Reference Citation Analysis]
78 Yang J, Li B, Zhao S, Du H, Du Y. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1. Onco Targets Ther 2020;13:6709-20. [PMID: 32764961 DOI: 10.2147/OTT.S253151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
79 Feng W, He J, Li S, Yang D, Li H, Yang G, Fu Q, Shan Y. Detection of Secretion of Exosomes from Individual Cell in Real-Time by Multifunctional Nanoelectrode-Nanopore Nanopipettes. Chinese Journal of Analytical Chemistry 2020;48:e20061-8. [DOI: 10.1016/s1872-2040(20)60029-9] [Reference Citation Analysis]
80 Ye Z, Wang S, Chen W, Zhang X, Chen J, Jiang J, Wang M, Zhang L, Xuan Z. Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer. Oncol Lett 2020;20:1409-17. [PMID: 32724383 DOI: 10.3892/ol.2020.11673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
81 Zhang W, Huang J, Tang Y, Yang Y, Hu H. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway. Ann Hepatol 2020;19:411-6. [PMID: 32536483 DOI: 10.1016/j.aohep.2020.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]